Trial record 2 of 3 for: Interleukin-2 in Metastatic Melanoma quan
Low-dose Cyclophosphamide and Outpatient IV Interleukin-2 in Metastatic Melanoma
This study has been withdrawn prior to enrollment.
(No participants enrolled)
Western Regional Medical Center
First Posted: April 17, 2013
Last Update Posted: August 24, 2017
Information provided by (Responsible Party):
Jordan Waypa, Western Regional Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|